Page 1484 - Small Animal Internal Medicine, 6th Edition
P. 1484

1456   PART XIV   Infectious Diseases


            Brown CM, et al. National Association of State Public Health Veter-  Lappin MR, et al. Use of serologic tests to predict resistance to feline
              inarians; compendium of animal rabies prevention and control.   herpesvirus 1, feline calicivirus, and feline parvovirus infection
  VetBooks.ir  Davis R, et al. Comparison of the mucosal immune response in   Larson LJ, et al. Effect of vaccination with recombinant canine dis-
                                                                  in cats. J Am Vet Med Assoc. 2002;220:38.
              J Am Vet Med Assoc. 2016;248(505):2016.
                                                                  temper virus vaccine immediately before exposure under shelter-
              dogs vaccinated with either an intranasal avirulent live culture
              or a subcutaneous antigen extract vaccine of Bordetella bronchi-  like conditions. Vet Ther. 2006;7:113.
              septica. Vet Ther. 2007;8:1.                       Larson LJ, et al. Three-year duration of immunity in dogs vacci-
            Dyer F, et al. Suspected adverse reactions, 2008.  Vet Rec. 2009;   nated with a canarypox-vectored recombinant canine distemper
              165:162.                                            virus vaccine. Vet Ther. 2007;8:101.
            Gershwin LJ. Adverse reactions to vaccination: from anaphylaxis to   Levy J, et al. American Association of Feline Practitioners’ feline ret-
              autoimmunity. Vet Clin North Am Small Anim Pract. 2018;48:279.  rovirus management guidelines. J Feline Med Surg. 2008;10:300.
            Greene CE. Environmental factors in infectious disease. In: Greene   Littman MP, et al. ACVIM consensus update on Lyme borreliosis
              CE, eds. Infectious diseases of the dog and cat. 4th ed. St Louis:   in dogs and cats. J Vet Intern Med. 2018;32:887.
              Elsevier; 2012:1078.                               Moore GE, et al. Adverse events after vaccine administration in
            Grosenbaugh DA, et al. Efficacy of a nonadjuvanted recombinant   cats: 2,560 cases (2002-2005). J Am Vet Med Assoc. 2007;231:94.
              FeLV vaccine and two inactivated FeLV vaccines when subject   Moore GE, et al. Adverse events diagnosed within 3 days of vaccine
              to consistent virulent FeLV challenge conditions.  Biologicals.   administration in pet dogs. J Am Vet Med Assoc. 2005;227:1102.
              2017;49:76.                                        Moore GE, Glickman LT. A perspective on vaccine guidelines and
            Grosenbaugh DA, Pardo MC. Fifteen-month duration of immunity   titer tests for dogs. J Am Vet Med Assoc. 2004;224:200.
              for the serovar  Grippotyphosa fraction of a tetravalent canine   Mucha D, et al. Lack of association between p53 SNP and FISS in
              leptospirosis vaccine. Vet Rec. 2018;182:665.       a cat population from Germany. Vet Comp Oncol. 2014;12:130.
            Hascall KL, et al. Prevalence of enteropathogens in dogs attending   Newbury S, et al. Prolonged intermittent virus shedding during an
              3 regional dog parks in Northern California. J Vet Intern Med.   outbreak of canine influenza A H3N2 virus infection in dogs in
              2016;30:1838.                                       three Chicago area shelters: 16 cases (March to May 2015). J Am
            Haun N, et al. Healthcare personnel attire and devices as fomites: a   Vet Med Assoc. 2016;248:1022.
              systematic review. Infect Control Hosp Epidemiol. 2016;37:1367.  Rodriguez L, et al. A bivalent live-attenuated influenza vaccine for
            Hofmann-Lehmann R, et al. Vaccination against the feline leu-  the control and prevention of H3N8 and H3N2 canine influenza
              kaemia virus: outcome and response categories and long-term   viruses. Vaccine. 2017;35:4374.
              follow-up. Vaccine. 2007;25:5531.                  Sánchez-Vizcaíno  F,  et al.  Use  of  vaccines  and  factors  associated
            Hosie MJ, et al. Matrix vaccination guidelines: 2015 ABCD rec-  with their uptake variability in dogs, cats and rabbits attend-
              ommendations for indoor/outdoor cats, rescue shelter cats and   ing a large sentinel network of veterinary practices across Great
              breeding catteries. J Feline Med Surg. 2015;17:583.  Britain. Epidemiol Infect. 2018;146:895.
            Huang C, et al. A dual-strain feline calicivirus vaccine stimulates   Scherk MA, et al. AAFP feline vaccination advisory panel report. J
              broader cross-neutralisation antibodies  than a single-strain   Feline Med Surg. 2013;15(785):2013.
              vaccine and lessens clinical signs in vaccinated cats when chal-  Srivastav A, et al. Comparative vaccine-specific and other
              lenged with a homologous feline calicivirus strain associated   injectable-specific risks of injection-site sarcomas in cats. J Am
              with virulent systemic disease. J Feline Med Surg. 2010;12:129.  Vet Med Assoc. 2012;241:595.
            Hurley KE, et al. An outbreak of virulent systemic feline calicivirus   Stull JW, Weese JS. Hospital-associated infections in small animal
              disease. J Am Vet Med Assoc. 2004;224:241.          practice. Vet Clin North Am Small Anim Pract. 2015;45:217.
            Jirjis F, et al. Protection against feline leukemia virus challenge for   Stull JW, et al. Reducing the risk of pet-associated zoonotic infec-
              at least 2 years after vaccination with an inactivated feline leuke-  tions. CMAJ. 2015;187:736.
              mia virus vaccine. Vet Ther. 2010;11:E1.           Summers SC, et al. Effect of modified live or inactivated feline
            Kass PH, et al. Multicenter case-control study of risk factors associ-  herpesvirus-1 parenteral vaccines on clinical and laboratory
              ated with development of vaccine-associated sarcomas in cats. J   findings following viral challenge. J Feline Med Surg. 2017;19:824.
              Am Vet Med Assoc. 2003;223:1283.                   Sykes JE, et al. ACVIM small animal consensus statement on lep-
            Kass PH. Prevention of feline injection-site sarcomas: is there a   tospirosis: diagnosis, epidemiology, treatment, and prevention. J
              scientific foundation for vaccine recommendations at this time?   Vet Intern Med. 2010;25(1):2010.
              Vet Clin North Am Small Anim Pract. 2018;48:301.   Weese JS, Stull J. Respiratory disease outbreak in a veterinary hos-
            Lappin MR, et al. Antimicrobial use guidelines for treatment of   pital associated with canine parainfluenza virus infection. Can
              respiratory tract disease in dogs and cats: antimicrobial guide-  Vet J. 2013;54:79.
              lines working group of the international society for companion   Westman ME, et al. Determining the feline immunodeficiency
              animal infectious diseases. J Vet Intern Med. 2017;31:279.  virus  (FIV)  status  of  FIV-vaccinated  cats  using  point-of-care
            Lappin MR, et al. Effects of a single dose of an intranasal feline   antibody kits. Comp Immunol Microbiol Infect Dis. 2015;42:43.
              herpesvirus 1, calicivirus, and panleukopenia vaccine on clini-  Whittemore JC, et al. Antibodies against Crandell Rees feline
              cal signs and virus shedding after challenge with virulent feline   kidney (CRFK) cell line antigens,  α-enolase, and annexin A2
              herpesvirus 1. J Feline Med Surg. 2006a;8:158.      in vaccinated and CRFK hyperinoculated cats. J Vet Intern Med.
            Lappin MR, et al. Interstitial nephritis in cats inoculated with Cran-  2010;24:306.
              dall Rees feline kidney cell lysates. J Feline Med Surg. 2006b;8:353.  Wilson S, et al. Vaccination of dogs with canine parvovirus type
            Lappin MR, et al. Investigation of the induction of antibodies   2b (CPV-2b) induces neutralising antibody responses to CPV-2a
              against Crandall Rees feline kidney cell lysates and feline renal   and CPV-2c. Vaccine. 2014;32:5420.
              cell lysates after parenteral administration of vaccines against   Yao PJ, et al. Incidence rates and risk factors for owner-reported
              feline viral rhinotracheitis, calicivirus, and panleukopenia in   adverse events following vaccination of dogs that did or did not
              cats. Am J Vet Res. 2005;66:506.                    receive a Leptospira vaccine. J Am Vet Med Assoc. 2015;247:1139.
   1479   1480   1481   1482   1483   1484   1485   1486   1487   1488   1489